Bottom line
GUSE vs CHTRX: the short answer
GUSE (Goldman Sachs Enhanced U.S. Equity ETF) and CHTRX (Invesco Charter Fund) share a meaningful slice of their top holdings — about 76% by weight.
GUSE is cheaper at 0.3% vs 1.01% — a difference of $71 a year per $10,000 invested.
Over five years, GUSE returned +15.1% a year vs +11.3% for CHTRX (reporting dates differ).
CHTRX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
GUSE vs CHTRX side by side
| GUSE | CHTRX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Goldman Sachs | Invesco |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.3% | 1.01% |
| Annual cost per $10k | $30 | $101 |
| 10-yr cost on $10k (prospectus) | $381 | $1,718 |
| Max front load | None | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +23.0% | +9.6% |
| 5-yr return (annualized) | +15.1% | +11.3% |
| 10-yr return (annualized) | +13.4% | +10.9% |
| Best quarter | +21.5% | +18.6% |
| Worst quarter | −18.7% | −20.6% |
| Net assets (fund) | $355.3M | $3.7B |
| Number of holdings | 122 | 69 |
| Portfolio turnover | 73% | 36% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GUSE | CHTRX | Difference |
|---|---|---|---|
| 2024 | +23.0% | +25.3% | −2.3% |
| 2023 | +28.4% | +23.0% | +5.3% |
| 2022 | −17.0% | −20.7% | +3.7% |
| 2021 | +26.9% | +27.4% | −0.5% |
| 2020 | +21.6% | +13.5% | +8.0% |
| 2019 | +31.7% | +29.0% | +2.7% |
| 2018 | −5.6% | −9.7% | +4.1% |
| 2017 | +33.4% | +13.3% | +20.2% |
| 2016 | +2.2% | +10.3% | −8.1% |
Source: Fund prospectus bar charts
Holdings overlap
17 of GUSE's top 25 holdings also appear in CHTRX's top 25.
| Holding | GUSE | CHTRX |
|---|---|---|
| Nvidia Corp | 7.91% | 8.51% |
| Apple Inc | 6.63% | 6.22% |
| Microsoft Corp | 5.20% | 6.65% |
| Amazon.com Inc | 4.37% | 4.79% |
| Alphabet Inc | 3.66% | 6.78% |
| Broadcom Inc | 3.19% | 3.67% |
| Meta Platforms Inc | 2.38% | 2.82% |
| Micron Technology Inc | 1.84% | 1.57% |
| Advanced Micro Devices Inc | 1.57% | 2.11% |
| Jp Morgan Chase & Company | 1.48% | 2.88% |
| Eli Lilly & Company | 1.47% | 2.08% |
| Johnson & Johnson | 1.46% | 1.52% |
| Mastercard Inc | 1.36% | 1.84% |
| Walmart Inc | 1.31% | 1.41% |
| Procter & Gamble Company (the) | 1.28% | 1.27% |
Source: SEC Form N-PORT
GUSE top 10
- Nvidia Corp — 7.91%
- Apple Inc — 6.63%
- Microsoft Corp — 5.20%
- Amazon.com Inc — 4.37%
- Alphabet Inc — 3.66%
- Broadcom Inc — 3.19%
- Alphabet Inc — 2.45%
- Meta Platforms Inc — 2.38%
- Tesla Inc — 1.97%
- Micron Technology Inc — 1.84%
CHTRX top 10
- NVIDIA Corp. — 8.51%
- Alphabet Inc. — 6.78%
- Microsoft Corp. — 6.65%
- Apple Inc. — 6.22%
- Amazon.com, Inc. — 4.79%
- Broadcom Inc. — 3.67%
- JPMorgan Chase & Co. — 2.88%
- Meta Platforms, Inc. — 2.82%
- Advanced Micro Devices, Inc. — 2.11%
- Eli Lilly and Co. — 2.08%
FAQ
What is the difference between GUSE and CHTRX?
Which is cheaper, GUSE or CHTRX?
Should I own both GUSE and CHTRX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.